Torrent Pharmaceuticals drops after announcing disappointing Q4 results

Torrent Pharmaceuticals dropped 2.35% to Rs 1,227 at 13:15 IST on BSE after consolidated net profit fell 46.72% to Rs 130 crore on 1.53% rise in total income to Rs 1254 crore in Q4 March 2015 over Q4 March 2014.

The Q4 result was announced after market hours on Friday, 15 May 2015.

Meanwhile, the S&P BSE Sensex was up 134.24 points or 0.49% at 27,458.24.

On BSE, so far 22,320 shares were traded in the counter as against average daily volume of 9,596 shares in the past one quarter.

The stock hit a high of Rs 1,244.65 and a low of Rs 1,175 so far during the day. The stock had hit a record high of Rs 1,334.75 on 15 April 2015. The stock had hit a 52-week low of Rs 569.50 on 19 May 2014.

The stock had outperformed the market over the past one month till 15 May 2015, falling 3.71% compared with Sensex's 5.12% fall. The scrip had also outperformed the market in past one quarter, gaining 9.18% as against Sensex's 6.09% fall.

The large-cap pharma firm has equity capital of Rs 84.61 crore. Face value per share is Rs 5.

Torrent Pharmaceuticals said EBITDA (earnings before interest, taxes, depreciation and amortization) fell 26% at Rs 259 crore in Q4 March 2015 over Q4 March 2014. Revenues fell 6% at Rs 1154 crore in Q4 March 2015 over Q4 March 2014. Adjusting for one-offs during the quarter, revenue growth is 10%, EBITDA growth is 34% and PAT growth is 60%.

Torrent Pharmaceuticals said that the board of directors of the company has recommended a final dividend of Rs 6.25 per equity share for the year ended 31 March 2015 (FY 2015).

Powered by Capital Market - Live News